Protective Effect of L-Arginine Intake on the Impaired Renal Vascular Responses in the Gentamicin-Treated Rats
暂无分享,去创建一个
F. Doran | Mehmet Seçilmiş | T. Inal | Y. Karataş | E. Singirik | K. Büyükafşar | A. Dikmen | Özlem Yorulmaz
[1] I. Karayaylali,et al. Effect of tempol (4‐hydroxy tempo) on gentamicin‐induced nephrotoxicity in rats , 2004, Fundamental & clinical pharmacology.
[2] B. Mayer,et al. Functional and analytical evidence for scavenging of oxygen radicals by L-arginine. , 2002, Molecular pharmacology.
[3] G. Polat,et al. Effect of trapidil, an antiplatelet and vasodilator agent on gentamicin-induced nephrotoxicity in rats. , 2001, Pharmacological research.
[4] J. Cooke,et al. Does ADMA cause endothelial dysfunction? , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[5] C. Can,et al. Protective effect of oral L-arginine administration on gentamicin-induced renal failure in rats. , 2000, European journal of pharmacology.
[6] P. Tulkens,et al. Aminoglycosides: Activity and Resistance , 1999, Antimicrobial Agents and Chemotherapy.
[7] D. Fulton,et al. NO-independent vasodilation to acetylcholine in the rat isolated kidney utilizes a charybdotoxin-sensitive, intermediate-conductance Ca(++)-activated K+ channel. , 1998, The Journal of pharmacology and experimental therapeutics.
[8] P. Vallance,et al. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. , 1997, Kidney international.
[9] R. Kikawada,et al. Effect of L-arginine on myoglobin-induced acute renal failure in the rabbit. , 1996, American Journal of Physiology.
[10] B. Ali,et al. Effect of superoxide dismutase treatment on gentamicin nephrotoxicity in rats. , 1996, General pharmacology.
[11] E. Isotani,et al. Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L‐arginine in regenerated endothelial cells , 1995, British journal of pharmacology.
[12] S. Bachmann,et al. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. , 1995, The American journal of physiology.
[13] B. Ali,et al. Influence of iron, deferoxamine and ascorbic acid on gentamicin-induced nephrotoxicity in rats. , 1994, General pharmacology.
[14] S. Klahr,et al. Role of arginine in health and in renal disease. , 1994, The American journal of physiology.
[15] J. Sabio,et al. Contribution of endothelium derived relaxing factors to acetylcholine induced vasodilatation in the rat kidney. , 1994, Cardiovascular Research.
[16] P. Vallance,et al. Effects of guanidino and uremic compounds on nitric oxide pathways. , 1994, Kidney international.
[17] C. Triggle,et al. Varying Extracellular [K+]: A Functional Approach to Separating EDHF‐ and EDNO‐Related Mechanisms in Perfused Rat Mesenteric Arterial Bed , 1993, Journal of cardiovascular pharmacology.
[18] P. Vanhoutte,et al. Heterogeneous distribution of endothelium-dependent relaxations resistant to NG-nitro-L-arginine in rats. , 1992, The American journal of physiology.
[19] L. Navar,et al. Role of endothelium-derived nitric oxide in the renal hemodynamic response to amino acid infusion. , 1992, The American journal of physiology.
[20] B. Klanke,et al. Importance of NO/EDRF for glomerular and tubular function: studies in the isolated perfused rat kidney. , 1992, Kidney international.
[21] S. Moncada,et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure , 1992, The Lancet.
[22] G. Burnstock,et al. NG‐Nitro‐l‐arginine methyl ester attenuates vasodilator responses to acetylcholine but enhances those to sodium nitroprusside , 1991, The Journal of pharmacy and pharmacology.
[23] B. Klanke,et al. Effect of arginine depletion on glomerular and tubular kidney function: studies in isolated perfused rat kidneys. , 1991, The American journal of physiology.
[24] S. E. Kays,et al. Iron supplementation increases gentamicin nephrotoxicity in rats. , 1991, The Journal of nutrition.
[25] C. Triggle,et al. Effects of Some Inorganic Divalent Cations and Protein Kinase C Inhibitors on Endothelium‐Dependent Relaxation in Rat Isolated Aorta and Mesenteric Arteries , 1991, Journal of cardiovascular pharmacology.
[26] R. Cohen,et al. Two mechanisms mediate relaxation by bradykinin of pig coronary artery: NO-dependent and -independent responses. , 1991, The American journal of physiology.
[27] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[28] J. Robinette,et al. Differences in vascular reactivity in models of ischemic acute renal failure. , 1991, Kidney international.
[29] C. Olbricht,et al. Alterations in lysosomal enzymes of the proximal tubule in gentamicin nephrotoxicity. , 1991, Kidney international.
[30] C. Baylis,et al. Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. , 1990, Journal of the American Society of Nephrology : JASN.
[31] S. Moncada,et al. Regional haemodynamic changes during oral ingestion of NG‐monomethyl‐l‐arginine or NG‐nitro‐l‐arginine methyl ester in conscious Brattleboro rats , 1990, British journal of pharmacology.
[32] S. Moncada,et al. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. , 1990, The American journal of physiology.
[33] R. Bhardwaj,et al. The effect of arginine and nitric oxide on resistance blood vessels of the perfused rat kidney , 1989, British journal of pharmacology.
[34] W. Bennett,et al. Microsomal protein synthesis inhibition: an early manifestation of gentamicin nephrotoxicity. , 1988, The American journal of physiology.
[35] S. Moncada,et al. Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.
[36] S. Moncada,et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.
[37] R. Furchgott. Role of endothelium in responses of vascular smooth muscle. , 1983, Circulation research.
[38] J. Knochel. The Pathophysiology of Uremia , 1981 .
[39] L. Ignarro,et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. , 1981, The Journal of pharmacology and experimental therapeutics.
[40] L. Ignarro,et al. Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N'-nitrosonornicotine and nitric oxide. , 1980, The Journal of pharmacology and experimental therapeutics.
[41] Z. Fan,et al. Pinacidil activates the ATP-sensitive K+ channel in inside-out and cell-attached patch membranes of guinea-pig ventricular myocytes , 2004, Pflügers Archiv.
[42] A. Ahluwalia,et al. NO contributes to EDHF-like responses in rat small arteries: a role for NO stores. , 2003, Cardiovascular research.
[43] D. Fliser,et al. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[44] S. Nussey,et al. Synthesis of NG, NG Dimethylarginine by Human Endothelial Cells , 1993 .
[45] W. Featherston,et al. Relative importance of kidney and liver in synthesis of arginine by the rat. , 1973, The American journal of physiology.